Biosimilars: Can They Break Through?

18 November 2015 Washington, D.C. Past Event

Location

Washington, D.C.

Agenda

8:00 a.m. Eastern
Partner David Rosen is a featured speaker for POLITICO’s Pro Health Care Report taking place on November 18, 2015, in Washington D.C.
The report, presented by the Alliance for Patient Access (AfPA) and titled “Biosimilars: Can They Break Through?” will include discussion on the policy issues surrounding biosimilars in the United States. Topics will include:

  • Given pending FDA regulations, what are the obstacles in getting biosimilars to market?
  • What are the concerns surrounding the labeling or prescriber information, and why is the issue of naming so hotly contested?
For more information, visit POLITICO: http://www.politico.com/events/2015/11/pro-health-care-report-biosimilars-can-they-break-through-215763

Related Services

Insights

FTC shuts down bogus debt collectors of “phantom debt”!
28 September 2021
Internet, IT & e-Discovery Blog
COVID-19 Vaccinations Required for Covered Contractors by December 8, 2021
28 September 2021
Legal News: Government Solutions & Government Procurement
Foley Weekly Automotive Report
28 September 2021
Coronavirus Resource Center:Back to Business
Podcast Episode 65: Justin Talbot, Senior Patent Agent
28 September 2021
Foley Career Perspectives
17th Annual IP Conference
12 November 2021
Chicago, IL
HLTH Conference 2021
17-20 October 2021
Boston, MA
Supply Chain and Sustainability Summit
12 October 2021
Webinar
30th Annual Law of Product Distribution & Franchise Seminar
7 & 20 October | 3 November 2021
Webinar

Biosimilars: Can They Break Through?

Location

Washington, D.C.

Agenda

8:00 a.m. Eastern